UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
May 1, 2026
NEBIUS GROUP N.V.
Schiphol Boulevard 165
1118 BG, Schiphol, the Netherlands.
Tel: +31 202 066 970
(Address, Including ZIP Code, and Telephone
Number,
Including Area Code, of Registrant’s Principal
Executive Offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F
¨
MERGER AGREEMENT WITH MAGICBYTE, INC.
(D/B/A EIGEN AI LABS)
On May 1, 2026, Nebius Group N.V. (“Nebius”),
Empire Acquisition Corp 1, Inc., a wholly owned subsidiary of Nebius (“Merger Sub 1”) and Empire Acquisition Corp
2, Inc., a wholly owned subsidiary of Nebius (“Merger Sub 2”) entered into an agreement and plan of merger (the “Merger
Agreement”) with MagicByte, Inc. (d/b/a Eigen AI Labs) (the “Target”), and certain other parties thereto, pursuant
to which the parties intend to effectuate two mergers (the “Mergers”), whereby Merger Sub 1 will merge with and into the Target,
with the Target continuing as the intermediate surviving corporation (the “Intermediate Surviving Entity”), then, immediately
thereafter, the Intermediate Surviving Entity will merge with and into Merger Sub 2, with Merger Sub 2 continuing as the surviving entity
and a wholly owned subsidiary of Nebius and the surviving corporation of the Merger.
The Merger Agreement contains
representations, warranties, indemnities and covenants customary for a transaction of this type. The boards of directors of both
Nebius and the Target have approved the transaction, and the transaction is not subject to the approval of the shareholders of
Nebius. The closing of the transactions contemplated under the Merger Agreement is also subject to customary closing conditions for
a transaction of this type, including antitrust clearance, and is expected to occur in the coming months.
The consideration under the Merger Agreement will
consist of up to approximately $98 million in cash, subject to adjustments, and approximately 3.8 million Nebius Class A shares,
in each case, subject to the terms and conditions set forth in the Merger Agreement. With respect to the stock consideration, the founders
and the other continuing employees will receive 15% of their applicable stock consideration at closing with the remaining stock consideration
subject to time-based restrictions on transfer, and forfeiture in certain cases, over a four-year period.
A press release announcing the signing of the
Merger Agreement is attached as Exhibit 99.1.
INCORPORATION BY REFERENCE
Exhibit 99.1 to this Report on Form 6-K is hereby incorporated
by reference into the Company’s Registration Statements on Form F-3ASR (File No. 333-286932) and Form S-8 (File No. 333-286934),
including any prospectuses forming a part of such Registration Statements, to the extent not superseded by documents or reports subsequently
filed or furnished.
INDEX TO EXHIBITS
| Exhibit No. |
Description |
| 99.1 |
Press release of Nebius Group N.V. dated May 1, 2026, announcing the acquisition of MagicByte, Inc. (d/b/a Eigen AI Labs). |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
NEBIUS GROUP N.V. |
| |
|
|
| Date: May 1, 2026 |
By: |
/s/ Boaz Tal |
| |
|
Boaz Tal |
| |
|
General Counsel |
Exhibit 99.1

Nebius agrees to
acquire Eigen AI, strengthening Nebius Token Factory as a frontier inference platform
| · | Combines
Eigen AI's industry-leading inference stack with Nebius's global capacity |
| · | Jointly
optimized endpoints achieved top rankings on Artificial Analysis across multiple models |
| · | Eigen
AI's founding team, including MIT HAN Lab researchers, will establish Nebius’s Bay
Area engineering and research presence |
Amsterdam, May 1, 2026 —
(NASDAQ: NBIS), the AI cloud company, today announced an agreement to acquire Eigen AI, a leading inference and model optimization
company.
The acquisition will
strengthen Nebius Token Factory as a frontier managed inference platform for production AI, combining a battle-tested optimization stack
with Nebius’s global compute capacity and AI cloud platform, and will add elite inference research talent to the company’s
established in-house AI R&D capabilities.
Following close, Eigen AI’s inference
and post-training optimization layers will be integrated directly into Nebius Token Factory, which provides enterprise-grade autoscaling
endpoints and fine-tuning pipelines across all major open-source models. The two companies have already delivered jointly optimized implementations
of leading open source models that ranked among the fastest on Artificial Analysis.
The acquisition also
accelerates Nebius’s expansion in the US. Eigen AI’s founding team – researchers who have developed optimization techniques
and tools the industry runs on – will join Nebius to establish a Nebius engineering and research presence in the San Francisco
Bay Area.
Roman Chernin, co-founder
and Chief Business Officer of Nebius, said:
“We are operating
in a capacity-scarcity world where AI builders need optimized inference and infrastructure scale. The integration of Eigen AI’s
optimization capabilities and founding team will establish Nebius Token Factory at the frontier of inference, offering customers market-leading
model performance and unit economics with massive compute capacity to back it at scale.”
Eigen AI’s founding
team brings deep expertise from research that shapes how the industry deploys inference today. Co-founders Ryan Hanrui Wang and Wei-Chen
Wang are alumni of MIT’s HAN Lab, led by Professor Song Han, a pioneering researcher in AI computing and model efficiency.
Ryan’s pioneering
Sparse Attention (SpAtten) work is the most-cited HPCA paper since 2020, while Wei-Chen received the MLSys 2024 Best Paper Award for
Activation-aware Weight Quantization (AWQ) quantization – now the standard for 4-bit model serving in production deployments. Co-founder
Di Jin, an MIT CSAIL PhD, brings deep expertise in post-training and large-scale model alignment, having contributed to Meta's Llama
3 and Llama 4 post-training and co-authored the CGPO RLHF framework.
Ryan Hanrui Wang,
co-founder and CEO of Eigen AI, said:
“We’re proud
to join Nebius and work alongside the Token Factory team to push the boundaries of inference performance. Nebius has built a world-class
AI cloud with a deep engineering culture that perfectly aligns with our own. Together, we are removing the friction of AI model customization
and deployment so developers can run models reliably in production without managing the underlying infrastructure.”
Inference is now the fastest-growing
segment of AI, forecast to account for about two-thirds of compute demand this year. Open-source model usage is rising alongside
it. With more workloads moving into production, the system optimization layer is becoming critical infrastructure.
Running inference efficiently
in production is inherently complex and requires deep expertise across the entire execution stack, from how models are represented, to
how GPU kernels execute them, to how workloads are scheduled in real time.
Open-source models typically
ship unoptimized, and newer architectures such as Mixture-of-Experts (MoE), Compressed Sparse Attention (CSA), reasoning, and long-context
models introduce additional challenges around memory, routing, and compute efficiency. Most teams do not have the capacity to solve these
problems in-house.
Eigen AI addresses this
challenge with a full-stack optimization approach that spans the entire model lifecycle. From post-training and fine-tuning to production
inference optimization, across all major open-source models in production demand, including GPT-OSS, Gemma, Qwen, Llama, Nemotron, DeepSeek,
GLM, Kimi and MiniMax.
By integrating Eigen
AI’s optimization layer directly into Nebius Token Factory, Nebius removes this bottleneck across the lifecycle. The system-, model-,
and kernel-level techniques developed by the Eigen team are designed to extract materially better performance from hardware out of the
box, delivering higher throughput and lower cost per inference without additional engineering overhead.
As a result, Nebius
Token Factory customers will benefit from faster time to production, significantly better unit economics, and the ability to adopt new
models more quickly. Existing Eigen AI customers will gain access to Nebius’s global AI infrastructure and platform capabilities.
The deal consideration
will be paid in a combination of cash and Nebius’s Class A shares with aggregate value as of signing, based on Nebius’s
30-day weighted average stock price, of approximately $643 million, subject to adjustments. The transaction is expected to close in the
coming weeks, subject to certain customary conditions, including antitrust clearance.
About Nebius
Nebius, the AI cloud
company, is building the full-stack platform for developers and companies to take charge of their AI future — from data and model
training to production deployment. Founded on deep in-house technological expertise and operating at scale with a rapidly expanding global
footprint, Nebius serves startups and enterprises building AI products, agents and services worldwide.
Nebius is listed on
Nasdaq (NASDAQ: NBIS) and headquartered in Amsterdam.
For more information please visit www.nebius.com
Contacts
Media relations: media@nebius.com
Investor relations: askIR@nebius.com
Disclaimer
Forward-looking statements
This press release
contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which involve risks and
uncertainties. All statements contained in this press release other than statements of historical fact, including, without limitation,
statements regarding our ability to complete the Eigen AI acquisition and our ability to integrate the Eigen AI team and to achieve the
synergies and other benefits anticipated, are forward-looking statements. The words "anticipate," "believe," "continue,"
"estimate," "expect," "guide," "intend," "likely," "may," "will"
and similar expressions and their negatives are intended to identify forward-looking statements.
These forward-looking
statements are subject to risks, uncertainties and assumptions, some of which are beyond our control. Actual results may differ materially
from the results predicted or implied by such statements, and our reported results should not be considered as an indication of future
performance. The potential risks and uncertainties that could cause actual results to differ from the results predicted or implied by
such statements include, among others: risks associated with acquisitions and the integration of businesses and teams; market, macroeconomic
and geopolitical conditions; technological developments; our ability to secure and retain clients; our ability to secure additional capital
to enable the growth of the business; as well as those risks and uncertainties related to our continuing businesses included under the
captions "Risk Factors" and "Operating and Financial Review and Prospects" in our Annual Report on Form 20-F
for the year ended December 31, 2025, filed with the Securities and Exchange Commission on April 30, 2026.
All information in
this press release is as of the date hereof (unless stated otherwise). Except as required by law, we undertake no obligation to update
or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date
on which the statements are made or to reflect the occurrence of unanticipated events.
In addition, statements
that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based
upon information available to us as of the date hereof and, while we believe such information forms a reasonable basis for such statements,
such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive
inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors
are cautioned not to unduly rely upon these statements.